A PYMNTS Company

New Antitrust Suit Claims Apple Monopolizes Heart-Rate Tech

By  |  May 26, 2021

A Silicon Valley company has filed an antitrust lawsuit accusing Apple of cornering the market for heart-rate monitoring technology for the Apple Watch, reported Reuters.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    In a complaint filed late on Tuesday night, May 25, AliveCor claimed that Apple shut out rivals by changing the heart-rate algorithm on its watch’s operating system, making rival technology incompatible.

    AliveCor sells KardiaBand, an Apple Watch wristband capable of recording an electrocardiogram, and SmartRhythm, an app that alerts users to irregular heartbeats.

    The privately held company accused Apple, whose market value exceeds US$2 trillion, of quietly “working in the background” to copy its ability to record an ECG on the Apple Watch, and to provide a separate app for heart-rate analysis.

    “As it has done multiple times over the years in other markets, Apple decided that it would not accept competition on the merits,” AliveCor stated in its complaint filed in San Francisco federal court.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.